BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 33162823)

  • 1. Emerging Roles of SIRT1 in Alcoholic Liver Disease.
    Ren R; Wang Z; Wu M; Wang H
    Int J Biol Sci; 2020; 16(16):3174-3183. PubMed ID: 33162823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of silent information regulator 1-serine/arginine-rich splicing factor 10-lipin 1 axis in the pathogenesis of alcohol fatty liver disease.
    Li Y; Zhou J
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1117-1125. PubMed ID: 28467182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression.
    Ramirez T; Li YM; Yin S; Xu MJ; Feng D; Zhou Z; Zang M; Mukhopadhyay P; Varga ZV; Pacher P; Gao B; Wang H
    J Hepatol; 2017 Mar; 66(3):601-609. PubMed ID: 27871879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of SIRT1 in fatty liver diseases.
    Ding RB; Bao J; Deng CX
    Int J Biol Sci; 2017; 13(7):852-867. PubMed ID: 28808418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrogenesis in alcoholic liver disease.
    Fujii H; Kawada N
    World J Gastroenterol; 2014 Jul; 20(25):8048-54. PubMed ID: 25009376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
    Yin H; Hu M; Liang X; Ajmo JM; Li X; Bataller R; Odena G; Stevens SM; You M
    Gastroenterology; 2014 Mar; 146(3):801-11. PubMed ID: 24262277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin 1 signaling and alcoholic fatty liver disease.
    You M; Jogasuria A; Taylor C; Wu J
    Hepatobiliary Surg Nutr; 2015 Apr; 4(2):88-100. PubMed ID: 26005675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.
    You M; Jogasuria A; Lee K; Wu J; Zhang Y; Lee YK; Sadana P
    Curr Mol Pharmacol; 2017; 10(3):226-236. PubMed ID: 26278388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease.
    Shree Harini K; Ezhilarasan D; Mani U
    Cell Biochem Funct; 2024 Jan; 42(1):e3916. PubMed ID: 38269515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 in alcoholic liver disease.
    Sun J; Fu J; Li L; Chen C; Wang H; Hou Y; Xu Y; Pi J
    Toxicol Appl Pharmacol; 2018 Oct; 357():62-69. PubMed ID: 30165058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
    Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
    Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?
    Boye A; Zou YH; Yang Y
    World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cAMP and phosphodiesterase signaling in liver health and disease.
    Wahlang B; McClain C; Barve S; Gobejishvili L
    Cell Signal; 2018 Sep; 49():105-115. PubMed ID: 29902522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin 1 alleviates alcoholic liver disease by inhibiting HMGB1 acetylation and translocation.
    Fu J; Deng W; Ge J; Fu S; Li P; Wu H; Wang J; Gao Y; Gao H; Wu T
    PeerJ; 2023; 11():e16480. PubMed ID: 38034869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol and unsaturated dietary fat induce unique patterns of hepatic ω-6 and ω-3 PUFA oxylipins in a mouse model of alcoholic liver disease.
    Warner DR; Liu H; Ghosh Dastidar S; Warner JB; Prodhan MAI; Yin X; Zhang X; Feldstein AE; Gao B; Prough RA; McClain CJ; Kirpich IA
    PLoS One; 2018; 13(9):e0204119. PubMed ID: 30256818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
    You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
    J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease.
    de Gregorio E; Colell A; Morales A; Marí M
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvianolic acid B protects against chronic alcoholic liver injury via SIRT1-mediated inhibition of CRP and ChREBP in rats.
    Zhang N; Hu Y; Ding C; Zeng W; Shan W; Fan H; Zhao Y; Shi X; Gao L; Xu T; Wang R; Gao D; Yao J
    Toxicol Lett; 2017 Feb; 267():1-10. PubMed ID: 27989594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol and the mechanisms of liver disease.
    Chen M; Zhong W; Xu W
    J Gastroenterol Hepatol; 2023 Aug; 38(8):1233-1240. PubMed ID: 37423758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.